Sequestration, workforce issues and step therapy reform are just some of the areas in which the ACR’s activities, via the Government Affairs Committee and member action, have made a positive difference for rheumatology practitioners.
At a virtual event with the chair of the Ways & Means Subcommittee on Health, RheumPAC donors were able to share concerns and recommendations about drug pricing policies and how they affect providers and patients.
The COVID-19 public health emergency (PHE) has been extended, effective April 21. The Biden administration has indicated it will likely extend the PHE through the end of the year.
Volunteer leaders who are community rheumatologists share their thoughts about the professional and personal benefits of serving on ACR committees and encourage others to get involved.
Frustrated with policies he viewed as obstacles to optimal patient care, Howard Yang, MD, RhMSUS, tried advocacy as a way to turn those feelings into positive action—an eye-opening and rewarding experience he strongly recommends.
When it comes to advocating for rheumatology, it’s never too early or late in your career to begin, and no effort is too small to have an impact, says Dr. Ziglar, a private practitioner and member of the Government Affairs Committee.
A better understanding of knowledge gaps and increased engagement of underrepresented communities are needed to diversify rheumatology patient data in clinical datasets, registries and randomized clinical trials.
State-level wins that ensure immunosuppressed patients can access COVID-19 vaccination show the power of coordinated efforts by volunteer leaders, staff and members to translate the ACR’s work into actionable public policy recommendations, then amplify those messages through member engagement.
The Centers for Medicare & Medicaid Services reopened the Extreme & Uncontrollable Circumstances application and indicated they will automatically apply the policy to individuals who do not submit data for 2020 Merit-based Incentive Payment System.